Over 35 CMOs / CDMOs in China claim to offer a variety of services related to development
Owing to benefits,such as reduced manufacturing costs, availability of cheap and skilled labor,and a supportive regulatory landscape, biopharmaceutical developers from acrossthe globe, are increasingly outsourcing their manufacturing operations to Chinabased CMOs. Further, in order to meet the growing demand for their services,Chinese CMOs are actively consolidating / expanding their capabilities throughpartnerships and / or dedicated expansion initiatives.
To order this 250+page report, which features 100+ figures and 120+ tables, please visit this link
The USD 2.6 billion(by 2030) financial opportunity within the China biopharmaceutical contractmanufacturing market has been analyzed across the following segments:
§ Type of Product
- API
- FDF
§ Type of ExpressionSystem Used
- Mammalian
- Microbial
- Others
§ Scale of Operation
- Preclinical / Clinical
- Commercial
§ Size of Manufacturer
- Small
- Mid-sized
- Large / Very Large
§ Type of Biologic
- Antibody
- Vaccine
- Others
The ChinaBiopharmaceutical Contract Manufacturing Market, 2020-2030 report features thefollowing companies, which we identified to be key players in this domain:
§ ChemPartner Biologics
§ JHL Biotech
§ JOINN Biologics
§ MabPlex
§ Mycenax Biotech
§ WuXi AppTec
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Case Study: Comparison of SmallMolecules and Large Molecules
5. Competitive Landscape
6. Company Profiles
7. Partnerships
8. Recent Expansions
9. Clinical Trial Analysis
10. Regional Capability Analysis
11. Capacity Analysis
12. Big Pharma BiopharmaceuticalManufacturing Initiatives in China
13. Make Versus Buy Decision Making Framework
14. Market Sizing and Opportunity Analysis
15. COVID-19 Impact on China BiopharmaceuticalCMO Market
16. SWOT Analysis
17. Future of the China Biopharmaceutical CMOMarket
18. Interview Transcripts
19. APPENDIX 1: TABULATED DATA
20. APPENDIX 2: LIST OF COMPANIES ANDORGANIZATIONS
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/china-biopharmaceutical-contract-manufacturing/313.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
